Pharmacology News

Making an early switch to oral antibiotic therapy from IV therapy is safe and effective for patients with low-risk Staphylococcus aureus bloodstream infection, researchers determined.

Gabapentinoid use has continued to increase in the last several years despite a “dearth of evidence” that supports the drug’s use, according to researchers.

A 55-year-old man new to the area presents to the ED complaining of excruciating left flank pain that radiates into his scrotum. He noted blood in the urine this morning and became worried enough to seek emergency care.

Gabapentinoid use was associated with severe exacerbation among users with COPD, supporting warnings from regulatory agencies about potentially serious adverse effects of the drugs, according to researchers.

Reduced drug use was linked to lower levels of craving, depression and other drug-related problems among individuals with stimulant use disorder, even if they did not achieve abstinence, according to a study published in Addiction.

Medical cannabis use for chronic pain may confer increased risk for de novo arrhythmia compared with nonuse or other treatments for chronic pain, researchers in Denmark reported.

In the landscape of health care, the year 2023 witnessed remarkable strides in the field of obesity medicine.

The FDA on Friday authorized a drug importation for Florida’s Agency for Health Care Administration that will enable the state to import prescription drugs from Canada, according to an agency news release.

An FDA investigation of popular weight-loss drugs has generated a storm of media attention and prompted patient questions.

Researchers linked more than 1 million deaths in Africa in 2019 to antimicrobial resistance, more than half of which were linked to just four pathogens.